From allergen genes to allergy vaccines.
IgE-mediated allergy is a hypersensitivity disease affecting more than 25% of the population. The structures of the most common allergens have been revealed through molecular cloning technology in the past two decades. On the basis of this knowledge of the sequences and three-dimensional structures of culprit allergens, investigators can now analyze the immune recognition of allergens and the mechanisms of allergic inflammation in allergic patients. Allergy vaccines have been constructed that are able to selectively target the aberrant immune responses in allergic patients via different pathways of the immune system. Here we review various types of allergy vaccines that have been developed based on allergen structures, results from their clinical application in allergic patients, and future strategies for allergen-specific immunotherapy and allergy prophylaxis.
Valenta
Rudolf
R
Medical University of Vienna, Austria. rudolf.valenta@meduniwien.ac.at
Ferreira
Fatima
F
Focke-Tejkl
Margarete
M
Linhart
Birgit
B
Niederberger
Verena
V
Swoboda
Ines
I
Vrtala
Susanne
S
D000485:Allergens / Q000737:chemistry / Q000235:genetics* / Q000276:immunology*; D000818:Animals; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy; D007073:Immunoglobulin E / Q000276:immunology; D007167:Immunotherapy; D014612:Vaccines / Q000276:immunology*
D000485:Allergens; D014612:Vaccines; D007073:Immunoglobulin E